Futures and options booming

Udgivet den 07-08-1996  |  kl. 13:36  |  

By Anuj Gangahar in New York

Published: March 10 2008 21:03 | Last updated: March 10 2008 21:03

The global volume of futures and options trading soared by 28 per cent last year, the largest annual increase since 2003, fuelled by a sharp rise in equity market volatility and a rush to commodity related contracts.

More than 15bn futures and options contracts changed hands during 2007 at 54 exchanges across the world, according to the Futures Industry Association.

EDITOR’S CHOICE
Market volatility brings class-action suits - Feb-04John Authers: Is this market story fact or fiction? - Feb-01Peaks and troughs of a volatile month - Jan-31Product salesmen beware of the 'black swan' effect - Jan-07Traders hit by ‘triple whammy’ - Dec-23The results show the rate of growth accelerating after a 19 per cent rise in 2006, 12 per cent in 2005, and 9 per cent in 2004. It is the largest volume rise since volume jumped 30 per cent from 6.2bn to 8.1bn in 2003 according to Galen Bughardt, director of research at Newedge Financial. He said: “Given that most of the top contracts have been around for years, if not decades, it is remarkable that we are still finding so much room to grow.”

He added that trading volume tends to ebb and flow in unpredictable ways, and the current wave of growth may well subside. “The good news is that volume levels are rising almost everywhere we look, and that speaks well to the long-term health of our industry.”

The upward trend in volume is taking place across all segments of the exchange-traded marketplace, some more markedly than others, according to the survey. Equity futures and options, both index and single stock, were the most powerful growth drivers. On a combined basis, equity products accounted for 64 per cent of the total volume last year, and 71 per cent of the total increase in volume. The sharp rise in volatility as a result of the credit crisis led to more traders hedging their exposure using derivatives contracts, or in some cases betting on future volatility.

Commodity products also had a burst of growth in 2007, helped by the greater adoption of electronic trading, the boom in biofuels, and stronger interest among institutional investors.

Growth is also taking place across all regions of the exchange-traded marketplace. China, though still largely closed to foreign participants, has become a huge force in agricultural and metals futures trading. The National Stock Exchange of India continues to move steadily up the lost of the largest derivatives exchanges, and Hong Kong Exchanges and Clearing more than doubled its volume last year.

Copyright The Financial Times Limited 2008

Udgivet af: NPinvestordk

Seneste nyheder

09:18 Zealand Pharma bankes i bund på børsen efter FDA-afvisning - aktionærer taber 5,3 mia. kr.
09:14 Aktier/åbning: Zealand Pharma falder tungt efter FDA-afvisning i rødt C25
09:11 Zealand Pharma bankes i bund på børsen efter FDA-afvisning
08:52 Obligationer/åbning: Små renteudsving før inflationsnyt fra USA
08:23 DNB sænker sin værdiansættelse af Zealand Pharmas Glepaglutid efter FDA-afvisning
08:13 Vigtigt rateindeks for Mærsk stiger for fjerde uge i træk
08:12 Væksten i dansk økonomi i tredje kvartal nedrevideret
08:09 Råvarer: Oliepriserne falder på styrket dollar og stagnerende kinesisk efterspørgsel
08:04 Vigtigt rateindeks for Mærsk stiger for fjerde uge i træk
07:59 Zealand Pharmas aktiekurs kan blive trykket af nye datakrav spår Nordnet
07:50 Aktier/tendens: Zealand Pharma i fokus efter amerikansk afvisning i ventet rødt marked
07:36 Per Aarsleff får hævet kursmål efter regnskab
07:25 Vægttab med Novos Cagrisema på 25 pct. eller mere kan give kursraket spår Nordnet
06:58 Obligationer/tendens: Afventende marked før amerikanske inflationstal
06:49 Mærsks asiatiske konkurrenter har uensartet udvikling fredag
06:42 Den japanske kerneinflation steg mere end ventet i november
06:34 Genmab får hævet anbefaling til "market perform" af Bernstein
06:34 Zealand Pharma får sænket kursmål efter afvist ansøgning fra FDA
06:34 Aarsleff får hævet kursmål af SEB efter regnskab
06:34 Zealand Pharma får afvist ansøgning hos FDA: "Vi er bestemt skuffede"